TPG Capital $207 million acquisition of Healthscope's Asian pathology operations

30/7/2018
Private acquisition

$ 207 million

Announced

30/7/2018


Overview:

  • TPG Capital  has acquired 39 pathology laboratories in Singapore, Malaysia and Vietnam from Healthscope.

Daniel Semerdzhiev - Data analyst

Jurisdictions:

Australia
China

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

Australia

Industry sector:

Pharmaceuticals and life sciences


Firm:

Party: Healthscope Ltd (Seller)

Lawyer: Emin Altiparmak